A final diagnosis of bladder cancer is made based on a pathological assessment using cystoscopy and biopsy. Recently, computed tomography CT and magnetic resonance imaging MRI have become widely used as screening tests for hematuria, and there are scattered reports of new imaging modalities such as CT urography CTU and diffusion-weighted MRI being useful in the detection of bladder cancer. However, there are no reports comparing CTU and MRI in this context. In the present study, we compared the bladder cancer detection abilities of CTU and MRI. We analyzed 58 cases of bladder cancer that had been examined by both CTU and bladder MRI. The objects of comparison were T2-weighted images and diffusion-weighted images for MRI and contrast CT images of the renal parenchyma and excretory phases for CTU. Bladder cancer was con rmed histopathologically via either biopsy or surgery for all cases. For patients with multiple bladder cancer, up to three lesions per case were included in the analysis. Two independent readers assessed all cases. Out of 91 lesions from 58 cases, Reader 1 detected 72 79.1 and 65 cases 71.4 , and Reader 2 detected 69 75.8 and 70 76.9 , using MRI and CTU, respectively. The -values for Reader 1 versus Reader 2 were 0.780 for MRI and 0.857 for CT, showing high diagnostic consistency. MRI showed a higher lesion detection rate than CTU, but this difference was not statistically significant. This study showed no significant difference in bladder cancer detection rate between CTU and MRI, con rming the value of MRI in the clinical diagnosis of bladder cancer.
Introduction
Bladder cancer is the most frequently occurring malignant tumor of the urinary tract 1, 2 . The most common symptom of bladder cancer is hematuria, and when hematuria is present and bladder cancer is clinically suspected, ultrasonography and cystoscopy are typically performed as screening examinations 1, 3 . Excretory urography is another urinary tract screening method that has long been used, but it has become increasingly replaced by CT urography CTU in recent times [4] [5] [6] [7] . CTU involves thin-section imaging of the urinary tract by multidetector CT MDCT during the excretory phase after intravenous injection of an iodine contrast agent, at high spatial and contrast resolution. CTU has proven especially useful in the diagnosis of renal pelvic and To whom corresponding should be addressed. urethral cancers 8, 9 , and in detecting bladder cancer [10] [11] [12] . A patient presenting with macroscopic hematuria is recommended to undergo CTU in combination with cystoscopy and ultrasonography, with a differential diagnosis including urothelial cancer 4, 13 . However, CTU uses contrast agents, meaning patients who suffer from reduced renal function or iodine allergy are precluded, and patients are subject to high X-ray exposure. In conjunction with the development of devices like 3T MRI equipment, new imaging modalities such as diffusion-weighted imaging are now being used in various domains for detecting cancer and determining its spread, with the major advantage that MRI does not involve contrast agents 14, 15 . To our knowledge, here we present the rst direct comparison of CTU and MRI for the detection of bladder cancer.
Methods
All cases for this study were selected from patients undergoing cystoscopy from Jan 2008 to Dec 2014 at Showa University Hospital. Of patients diagnosed with bladder cancer based on biopsy or surgery, we selected 58 who had undergone CTU and bladder MRI examinations within one month of each other. The mean age was 67 years range : 35-84 years , with 46 males and 12 females. We selected only cases for which a minimum of T2-weighted and diffusion-weighted MRI imaging was implemented. The MRI comprised whole-body 3T MRI MAGNETOM Trio, A Tim System 3T : Siemens, Germany and whole-body 1.5T MRI MAG-NETOM Avanto 1.5T : Siemens, Germany ; MAGNETOM ESSENZA 1.5T : Siemens, Germany ; Singa HDxt 1.5T : G.E., USA , with 3T devices used for 45 cases and 1.5T devices for 13 cases. The CT procedures comprised 64-slice MDCT SOMATOM Sensation 64 : Siemens, Germany , 128-slice MDCT SOMATOM Definition AS : Siemens, Germany , and 4-slice MDCT Light Speed Plus : G.E., USA . After simple CT from the upper pole of the kidney to the bladder, 100 ml of non-ionic iodine contrast agent 300 mg/ml was intravenously injected for CTU : after 80 seconds, the renal parenchyma phase was imaged from above the diaphragm to the pubis, and after 8 minutes, the excretory phase was imaged from the upper pole of the kidney to the bladder. If suf cient contrast was not achieved in the 8-min images, those hematuria patients 40 years and older were subjected to a second round of imaging, 12 minutes after the initial injection, from the upper-pole kidney to the bladder. Three-dimensional images were constructed using excretory phase images, including maximum intensity projection MIP and volume rendering VR images. For simple CT, renal parenchyma phase CT, and excretory phase CT, 5-mm axial images were captured; coronal images were also captured for the excretory phase.
In the evaluation of bladder cancer, up to three lesions per patient were included in analysis for cases of multiple bladder cancer. Two independent evaluators Reader 1 and Reader 2 diagnosed the presence of bladder tumors using MRI and CT axial images. T2-weighted and diffusion-weighted images were interpreted and evaluated for MRI, while post-contrast images of the renal parenchyma and excretory phases were examined for CTU. For cases where bladder cancer was diagnosed based on histopathological ndings, the diagnosis results for CT and MRI images by Reader 1 and Reader 2 were compared with cystoscopic and surgical ndings. Statistical analysis by McNemar s test was conducted using SPSS version 17.0. P-values of 0.05 were considered statistically signi cant. Ethical approval for this retrospective study was granted by the institutional review board, and patient consent was not required.
Results
The observed bladder cancers showed slightly high signals in T2-weighted MRI images and high signals in diffusion-weighted MRI images. In contrast, the, CT images exhibited strongly enhanced signals after the administration of contrast agent for 80 cases ; in the excretory phase, contrast defects were observed inside bladders lled with contrast agent Fig. 1-3 Using both MRI and CTU for 91 lesions from 58 cases, Reader 1 detected 72 79.1 and 65 cases 71.4 , respectively, and Reader 2 detected 69 75. 8 and 70 76.9 cases, respectively Table 1 . The -values for Reader 1 versus Reader 2 were 0.780 for MRI and 0.857 for CT, showing high diagnostic consistency. MRI showed a higher lesion detection rate than CTU, but this difference was not statistically signi cant, with P-values of 0.065 for Reader 1 and 1.00 for Reader 2.
Discussion
One of the characteristic features of bladder carcinoma is the multitude of occurrences in time and space, thus there is a high frequency of recurrence. In this study, there were multiple lesions in 21 cases ; however, we evaluated only three lesions maximum per bladder because of the dif culty in evaluating all lesions in those patients with multiple bladder tumors. Urothelial neoplasms of the urinary bladder may be subdivided into papillary papillomas, low malignant potential, and papillary carcinoma and non-papillary urothelial carcinoma in situ and invasive categories. In this study, we did not consider the distinct morphological features of the bladder carcinoma with CT or MRI, although further studies should add such a comparison because these morphological features can be important in staging of the bladder carcinoma.
A de nitive diagnosis of bladder cancer is generally obtained by rst con rming the lesion by cystoscopy or transabdominal ultrasonography, followed by histopathological con rmation of tumor tissue excised by a trans-urethral resection of bladder tumor TURBT procedure 12, 17 . Trans-abdominal ultrasonography is a non-invasive, convenient testing method that is useful for diagnosing bladder cancer ; however, it can be dif cult to evaluate the whole bladder by this procedure due to abdominal gas and poor objectivity. Cystoscopy is the most reliable testing method, but it is highly invasive, and not always easy to perform. Cystoscopy should be done when urine cytology is positive, but no bladder tumor is detected on diagnostic imaging, because it is not possible to detect at lesions or carcinoma in situ on CT or MRI. However, it may be useful for performing CT or MRI prior to cystoscopy because the result gives the urologist gross information of the existence or non-existence of the bladder carcinoma.
CTU has gained wider use recently as a method for urinary tract screening, and high detection rates for bladder cancer are visible in past reports 11, 12 . Among bladder cancer detection rates in the literature, 93 reported by Turney et al 11 is high compared with our rates of 71.4 Reader 1 and 76.9
Reader 2 , but given that cystoscopy was not performed in our study when no abnormality was present on CTU, it is possible that our values include false negatives. However, our rates support a study by Sadow et al 12 who reported 79 detection in comparing cystoscopy and CTU ndings for all of their patients.
MRI offers excellent tissue contrast, and thus permits satisfactory bladder cancer detection without the use of contrast agents 14 . In addition, the recently developed diffusionweighted imaging is highly useful for tumor detection generally, and in bladder cancer detection speci cally 18, 19 , with reported rates of 98.1 18 and 89 19 . Compared with our own results of 79.1 Reader 1 and 75.1 Reader 2 , these detection rates are quite high, probably due to differences in tumor size among the studies. Speci cally, Abou-El-Ghar et al 18 detected a mean bladder tumor size of 29 mm and Halefoglu 19 detected a mean size of 36.6 mm, much larger than the values in the present study. This difference seems particularly affected by the large number of tumors less than 20 mm in diameter in our cases, for which the mean maximum diameter of tumors was 19.0 mm. In our comparison of CTU renal parenchyma phase and excretory phase versus noncontrast MRI T2-weighted and diffusion-weighted , the bladder cancer detection rate by MRI was higher for both Reader 1 and Reader 2, but this difference was not statistically signi cant. Cystoscopy is the gold standard for bladder cancer detection, but it has been reported that this invasive test can be omitted, patient condition permitting, by conducting CTU instead [20] [21] [22] . Our results suggest that MRI, which requires neither X-ray exposure nor the use of contrast agents, possesses an essentially equivalent detection rate to CTU for bladder cancer. We therefore propose that MRI, with its even-lower invasiveness than CT, could be a superior screening method for bladder cancer.
This research had the following limitations. First, we analyzed only cases of bladder cancer diagnosed by cystoscopy. For this reason, the only measure that was compared between screening methods was detection rate. However, it is clinically dif cult to conduct MRI for all patients with suspected bladder cancer based on hematuria, and a prospective study would be necessary to compare CTU and MRI with an adequate measure of specificity. Compared with using cystoscopy, our bladder cancer detection rates for CTU and MRI were certainly not high. Since CTU and MRI were limited to three lesions in cases of multiple bladder cancer, the detection rates would likely drop even lower if the remaining small tumors were included. For MRI to be highly useful as a screening examination for bladder cancer, further progress in MRI equipment as well as improvements in diagnostic techniques are needed.
